von Eije Karin Jasmijn, ter Brake Olivier, Berkhout Ben
Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
J Virol. 2008 Mar;82(6):2895-903. doi: 10.1128/JVI.02035-07. Epub 2007 Dec 12.
RNA interference (RNAi) is a cellular mechanism in which small interfering RNAs (siRNAs) mediate sequence-specific gene silencing by cleaving the targeted mRNA. RNAi can be used as an antiviral approach to silence the human immunodeficiency virus type 1 (HIV-1) through stable expression of short-hairpin RNAs (shRNAs). We previously reported efficient HIV-1 inhibition by an shRNA against the nonessential nef gene but also described viral escape by mutation or deletion of the nef target sequence. The objective of this study was to obtain insight in the viral escape routes when essential and highly conserved sequences are targeted in the Gag, protease, integrase, and Tat-Rev regions of HIV-1. Target sequences were analyzed of more than 500 escape viruses that were selected in T cells expressing individual shRNAs. Viruses acquired single point mutations, occasionally secondary mutations, but-in contrast to what is observed with nef-no deletions were detected. Mutations occurred predominantly at target positions 6, 8, 9, 14, and 15, whereas none were selected at positions 1, 2, 5, 18, and 19. We also analyzed the type of mismatch in the siRNA-target RNA duplex, and G-U base pairs were frequently selected. These results provide insight into the sequence requirements for optimal RNAi inhibition. This knowledge on RNAi escape may guide the design and selection of shRNAs for the development of an effective RNAi therapy for HIV-1 infections.
RNA干扰(RNAi)是一种细胞机制,其中小干扰RNA(siRNA)通过切割靶向mRNA介导序列特异性基因沉默。RNAi可作为一种抗病毒方法,通过短发夹RNA(shRNA)的稳定表达来沉默1型人类免疫缺陷病毒(HIV-1)。我们之前报道了一种针对非必需nef基因的shRNA对HIV-1的有效抑制作用,但也描述了通过nef靶序列的突变或缺失导致的病毒逃逸。本研究的目的是深入了解当HIV-1的Gag、蛋白酶、整合酶和Tat-Rev区域中的必需且高度保守序列被靶向时的病毒逃逸途径。对在表达单个shRNA的T细胞中选择的500多种逃逸病毒的靶序列进行了分析。病毒获得了单点突变,偶尔还有二级突变,但与nef基因情况不同的是,未检测到缺失。突变主要发生在靶位点6、8、9、14和15,而在位点1、2、5、18和19未选择任何突变。我们还分析了siRNA-靶RNA双链体中的错配类型,发现G-U碱基对经常被选择。这些结果为最佳RNAi抑制的序列要求提供了见解。关于RNAi逃逸的这一知识可能会指导shRNA的设计和选择,以开发针对HIV-1感染的有效RNAi疗法。